Brachytherapy
Volume 6, Issue 1 , Pages 2-8 , January 2007

Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the United States

  • Steven J. Frank

      Affiliations

    • Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd – Unit 97, Houston, TX 77030, USA. Tel.: +1-713-563-2300; fax: +1-713-563-2366.
    • ,
  • Peter D. Grimm

      Affiliations

    • The Seattle Prostate Institute, Seattle, WA
    • ,
  • John E. Sylvester

      Affiliations

    • The Seattle Prostate Institute, Seattle, WA
    • ,
  • Gregory S. Merrick

      Affiliations

    • Schiffler Cancer Center, Wheeling Hospital, Wheeling, WV
    • ,
  • Brian J. Davis

      Affiliations

    • Department of Radiation Oncology, Mayo College of Medicine, Rochester, MN
    • ,
  • Anthony Zietman

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA
    • ,
  • Brian J. Moran

      Affiliations

    • Chicago Prostate Cancer Center, Westmont, IL
    • ,
  • David C. Beyer

      Affiliations

    • Arizona Oncology Services, Scottsdale, AZ
    • ,
  • Mack Roach III

      Affiliations

    • Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA
    • ,
  • Daniel H. Clarke

      Affiliations

    • Inova Alexandria Hospital, Alexandria, VA
    • ,
  • Richard G. Stock

      Affiliations

    • Department of Radiation Oncology, The Mount Sinai Hospital, New York, NY
    • ,
  • W. Robert Lee

      Affiliations

    • Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC
    • ,
  • Jeff M. Michalski

      Affiliations

    • Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO
    • ,
  • Kent E. Wallner

      Affiliations

    • Department of Veteran Affairs, Seattle, WA
    • ,
  • Mark Hurwitz

      Affiliations

    • Department of Radiation Oncology, Brigham & Women's Hospital, Boston, MA
    • ,
  • Louis Potters

      Affiliations

    • New York Prostate Institute, Oceanside, NY
    • ,
  • Deborah A. Kuban

      Affiliations

    • Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Bradley R. Prestidge

      Affiliations

    • Texas Cancer Clinic, San Antonio, TX
    • ,
  • Robyn Vera

      Affiliations

    • The Seattle Prostate Institute, Seattle, WA
    • ,
  • Shannon Hathaway

      Affiliations

    • The Seattle Prostate Institute, Seattle, WA
    • ,
  • John C. Blasko

      Affiliations

    • The Seattle Prostate Institute, Seattle, WA

Received 14 July 2006 ,Revised 25 September 2006 ,Accepted 27 September 2006.

References 

  1. Ragde H, Blasko JC, Grimm PD, et al. Brachytherapy for clinically localized prostate cancer: Results at 7- and 8-year follow-up. Semin Surg Oncol. 1997;13:438–443
  2. Holm HH. The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol. 1997;13:431–437
  3. Blasko JC, Wallner K, Grimm PD, et al. Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma. J Urol. 1995;154:1096–1099
  4. Zelefsky MJ, Moughan J, Owen J, et al. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer. Int J Radiat Oncol Biol Phys. 2004;59:1053–1061
  5. Stone NN, Stock RG. Permanent seed implantation for localized adenocarcinoma of the prostate. Curr Urol Rep. 2002;3:201–206
  6. Ragde H, Blasko JC, Grimm PD, et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 1997;80:442–453
  7. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969–974
  8. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997;277:1445–1451
  9. Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44:789–799
  10. Grimm PBJ, Sylvester J. Clinical selection issues for permanent seed prostate brachytherapy. J Brachyther Int. 2001;17:143–152
  11. Potters L, Morgenstern C, Calugaru E, et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol. 2005;173:1562–1566
  12. Merrick GS, Butler WM, Wallner KE, et al. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005;161:32–43
  13. Merrick GS, Butler WM, Galbreath RW, et al. Biochemical outcome for hormone-naive patients with Gleason score 3 + 4 versus 4 + 3 prostate cancer undergoing permanent prostate brachytherapy. Urology. 2002;60:98–103
  14. Merrick GS, Butler WM, Galbreath RW, et al. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland. Int J Radiat Oncol Biol Phys. 2002;52:664–673
  15. Merrick GS, Butler WM, Galbreath RW, et al. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy. Cancer J. 2002;8:79–80
  16. Butler WM, Merrick GS. Myths and fallacies in permanent prostate brachytherapy. Med Dosim. 2003;28:155–165
  17. D'Amico AV, Renshaw AA, Cote K, et al. Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease. Am J Clin Oncol. 2004;22:3726–3732
  18. Kestin LL, Goldstein NS, Vicini FA, et al. Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy. J Urol. 2002;168:1994–1999
  19. Rossi PJ, Clark PE, Papagikos MA, et al. Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer. Urology. 2006;67:349–353
  20. Epstein JI. The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer. Semin Surg Oncol. 1998;16:124–128
  21. D'Amico AV. Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer. Cancer J. 2001;7:375–376
  22. Potters L, Purrazzella R, Brustein S, et al. The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2003;56:749–754
  23. D'Amico AV, Renshaw AA, Schultz D, et al. The impact of the biopsy Gleason score on PSA outcome for prostate cancer patients with PSA < or = 10 ng/ml and T1c, 2a: Implications for patient selection for prostate-only therapy. Int J Radiat Oncol Biol Phys. 1999;45:847–857
  24. Herman CM, Kattan MW, Ohori M, et al. Primary Gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer: A multivariate analysis of 823 men treated with radical prostatectomy. Am J Surg Pathol. 2001;25:657–660
  25. Potters L, Fearn P, Kattan MW. External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer. Brachytherapy. 2002;1:36–41
  26. Thomadsen BR, Rivard MJ, Butler WM. Brachytherapy physics second edition. 2nd ed.. Madison, WI: Medical Physics Publishing; 2005;

PII: S1538-4721(06)00302-3

doi: 10.1016/j.brachy.2006.09.004

Brachytherapy
Volume 6, Issue 1 , Pages 2-8 , January 2007

Article Tools